Aryaakhil · Newsroom
Cooper Pharma Announces Launch of Hormone ANAZBOL (Anastrozole 1mg Tablets)
Cooper Pharma today announced that one of its wholly owned hormone product ANAZBOL that has launched in head office, Delhi, India.
September 19, 2019
Cooper Pharma Announces Launch of Hormone Clombolic (Clomiphene Citrate 50mg)
Cooper Pharma today announced that one of its wholly owned hormone product CLOMBOLIC that has launched in head office, Delhi, India.August 20, 2019
Cooper Pharma Announces Launch of Hormone PROVIBOLIC (Mesterolone 25mg )
Cooper Pharma today announced that one of its wholly owned hormone product PROVIBOLIC that has launched in head office, Delhi, India.
August 6, 2019
Cooper Pharma Announces Launch of Hormone TURBOLIC (Turinabol Tablet 10mg)
Cooper Pharma today announced that one of its wholly owned hormone product TURBOLIC that has launched in head office, Delhi, India.July 19, 2019
Cooper Pharma Announces Launch of Hormone PROBOLIC (Testosterone Propionate 100mg)
Cooper Pharma today announced that one of its wholly owned hormone product PROBOLIC that has launched in head office, Delhi, India.
May 29, 2019
Cooper Pharma Announces Launch of Hormone WINOBOLIC (Stanozolol Tablet 5mg/10mg)
Cooper Pharma today announced that one of its wholly owned hormone product WINOBOLIC that has launched in head office, Delhi, India.
March 13, 2019
Cooper Pharma Announces Launch of Hormone WINOBOLIC (Stanozolol Injection 50mg/ml)
Cooper Pharma today announced that one of its wholly owned hormone product WINOBOLIC that has launched in head office, Delhi, India.
October 22, 2018
Cooper Pharma Announces Launch of Hormone DECABOLIC (Nandrolone Decanoate Injection USP 250mg/ml).
Cooper Pharma announced that one of its wholly owned hormone product DECABOLIC that has launched in 5 new markets across Middle-East and Latin America.August 16, 2018
Cooper Pharma Introduces T3BOLIC (Levothyroxine Tablets BP 50 mcg)
Cooper Pharma is a leader in generic/hormones drugs in India and has introduced new molecules to help address patients' needs.February 17, 2018